The world’s first and only meeting where you can hear the latest efforts to understand and target cancer stem cells from the leading companies in the field.
Understand how the industry is using a growing understanding of cancer stem cells or tumor-initiating cells to dramatically improve cancer therapies, and what this will mean for your business and research.
Showcase your ideas and innovative research in front of the most influential cancer stem cells business leaders and scientists.
Get the latest perspectives from the investment community on the cancer stem cells field, and learn how you can make your business and research more attractive to potential investors.
For further information, the scientific agenda and any applicable reduced rates, please contact directly:
Neil Ashman, Biorbis Delegate Director
+ 44 (0) 203 141 8726
